Accuray inks deal to buy Morphormics for nearly $6M
Accuray has signed a definitive agreement to acquire Morphormics, a privately held company founded by University of North Carolina at Chapel Hill faculty members based on their research in autosegmentation of medical images.
Morphormics develops medical imaging software systems that automatically recognize and extract anatomical structures from medical images. The agreement provides that Accuray will pay approximately $5.7 million.
In 2008, Sunnyvale, Calif.-based Accuray began licensing Morphormics' autocontouring technology, which identifies and draws the boundaries of the prostate and surrounding critical structures. This enables the treatment planning software to focus the radiation dose on the prostate and minimize the delivery of radiation to surrounding critical structures, according to the company.
With the acquisition of Morphormics, Accuray plans to extend autocontouring capabilities for both the CyberKnife Robotic Radiosurgery System and the TomoTherapy System to improve disease-specific workflows.
Morphormics develops medical imaging software systems that automatically recognize and extract anatomical structures from medical images. The agreement provides that Accuray will pay approximately $5.7 million.
In 2008, Sunnyvale, Calif.-based Accuray began licensing Morphormics' autocontouring technology, which identifies and draws the boundaries of the prostate and surrounding critical structures. This enables the treatment planning software to focus the radiation dose on the prostate and minimize the delivery of radiation to surrounding critical structures, according to the company.
With the acquisition of Morphormics, Accuray plans to extend autocontouring capabilities for both the CyberKnife Robotic Radiosurgery System and the TomoTherapy System to improve disease-specific workflows.